11 Feb 2019 10:11
Hikma Pharmaceuticals PLC
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Said Darwazah
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Said Darwazah |
2 | Reason for the notification | |
a) | Position/status | Executive Chairman |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Pledge by Darhold Limited of 1,800,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of J. Safra Sarasin Ltd. The Executive Chairman is a director of and shareholder in Darhold Limited with an equity interest of 21.76%. |
c) | Price(s) and volume(s) | Price(s): £0.00p Volume(s): 1,800,000 |
d) | Aggregated information | Aggregated volume: 1,800,000 Price: £0.00p |
e) | Date of the transaction | 7 February 2019 |
f) | Place of the transaction | Amman |
Mazen Darwazah
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Mazen Darwazah |
2 | Reason for the notification | |
a) | Position/status | Executive Vice Chairman |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Pledge by Darhold Limited of 1,800,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of J. Safra Sarasin Ltd. The Executive Vice Chairman is a director of and shareholder in Darhold Limited with an equity interest of 10.96%. |
c) | Price(s) and volume(s) | Price(s): £0.00p Volume(s): 1,800,000 |
d) | Aggregated information | Aggregated volume: 1,800,000 Price: £0.00p |
e) | Date of the transaction | 7 February 2019 |
f) | Place of the transaction | Amman |
Mohammed 'Ali' Al-Husry
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Mohammed 'Ali' Al-Husry |
2 | Reason for the notification | |
a) | Position/status | Non-Executive Director |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Pledge by Darhold Limited of 1,800,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of J. Safra Sarasin Ltd. The Non-Executive Director is a director of and shareholder in Darhold Limited with an equity interest of 8.05%. |
c) | Price(s) and volume(s) | Price(s): £0.00p Volume(s): 1,800,000 |
d) | Aggregated information | Aggregated volume: 1,800,000 Price: £0.00p |
e) | Date of the transaction | 7 February 2019 |
f) | Place of the transaction | Amman |
Peter SpeirsCompany Secretary, responsible for releasing this announcement+44 (0) 20 7399 2760
Hikma Pharmaceuticals (HIK)